Lyell Immunopharma logo
Lyell Immunopharma
LYEL | NASDAQ
Chart Builder DCF Calculator
$14.65
+$0.35 (+2.45%)
At close: Nov 16, 2026, 4:00 PM ET
$14.65
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Lyell Immunopharma Cash Flow Statement

Cash flow statement explained
Fiscal Quarter
Period Ending
Q3 2026
Sep 30, 2026
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
-45.53M -44.76M -24.15M -140.72M -38.85M -42.68M -52.2M -191.94M -44.58M -45.81M -60.67M -52.93M -50.85M -63.89M -66.96M -8.4M -70.25M -36.32M -68.14M -83.71M -48.88M -62.6M -55.04M
2.05M 2.22M 2.33M 2.4M 2.57M 3.14M 3.44M 5.03M 4.68M 4.9M 5.02M 5.06M 5.1M 4.54M 5.03M 4.59M 4.17M 3.73M 3.97M 3.99M 4.09M 3.01M 3M
4.51M 4.53M – 25.57M 5.23M 5M 6.02M 8.08M 7.62M 8.28M 9.16M 8.46M 10.52M – 13.88M – – – – – 13.04M 15.25M –
6.48M 9.32M -3.47M 347K 643K -645K -7.9M 2.07M 1.61M -437K -3.12M 1.3M 3.84M 3.2M -6.38M -42.87M 1.73M -36.22M -5.33M 3.52M 6.73M -911K -5.41M
-2.23M -3.77M -15.61M 79.83M 2.61M 963K -2.45M 131.55M -3.8M -4.52M 7.71M -2.95M -4.88M 16.61M 6.15M 6.93M 27.23M 26.24M 18.71M 42.93M 511K 10.95M 23.23M
– – – – – – – – – – – – – – – – – – – – – – –
6.62M 7.85M -1.08M 672K -136K -876K -9.55M 34K 1.04M -954K -3.24M 1.72M 2.43M 3.58M -4.31M -43.39M 1.75M -37.98M -2.39M 3.62M 5.74M -565K -4.78M
-34.57M -33.92M -38.51M -32.25M -28.58M -34.46M -54.74M -47.24M -35.04M -38.09M -42.02M -40.64M -37.69M -39.16M -46.21M -40.27M -37.1M -44.33M -47.85M -33.17M -25.49M -33.95M -33.6M
-66K -256K -89K -304K -62K -168K -246K -44K -59K -331K -30K -25K -195K -933K -1.53M -4.58M -2.79M -7.17M -9.73M -10.27M -11.6M -24.45M -19.19M
– – – – 263K – – -31.35M – – – – – – – – – – – -40K – 40K –
-43.58M -53.52M -37.18M -42.8M -70.99M -80.7M -84.41M -38.8M -131.43M -116.46M -108.01M -256.79M -78.28M -33.26M -108.56M -59.67M -160.79M -89.66M -96.2M -133.92M -275.31M -215.94M -48.29M
97.24M 69.39M 54.65M 52.91M 74.14M 93.52M 154.12M 123.7M 133.41M 161.8M 130.04M 156.12M 178.15M 187.1M 142.25M 110.9M 106.5M 121.85M 79.81M 70.33M 142.04M 200.87M 204.16M
– 5K – -41.17M – – – – – – – – – – – – – – – – – – –
53.59M 15.62M 17.38M -31.37M 3.35M 12.65M 69.47M 53.51M 1.92M 45.01M 21.99M -100.69M 99.67M 152.91M 32.15M 46.65M -57.09M 25.02M -26.12M -73.9M -144.91M -39.47M 136.68M
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – -69K – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
– 50M – -1K – -1K 1K – – – -76K -123K -215K -50K – -981K -367K 887K – – 529K 630K –
41K 522K 51.72M 222K 50M 183K 1K 437K – 862K 27K 759K -143K 1.2M -69K 863K 4.76M 2.46M 2.56M 7.4M -531K 393.49M 884K
19.07M -17.78M 30.59M -63.39M 24.77M -21.63M 14.73M 5.3M -33.12M 7.77M -20M -140.57M 61.84M 114.95M -14.13M 7.24M -89.43M -16.86M -71.23M -99.68M -170.94M 320.07M 103.96M
-34.63M -34.18M -38.6M -32.56M -28.64M -34.63M -54.98M -47.29M -35.1M -38.43M -42.05M -40.66M -37.88M -40.09M -47.75M -44.85M -39.89M -51.5M -57.59M -43.44M -37.09M -58.39M -52.79M
-39.15M -38.71M -38.6M -58.12M -33.87M -39.63M -61.01M -55.37M -42.72M -46.71M -51.2M -49.12M -48.4M -40.09M -61.63M -44.85M -39.89M -51.5M -57.59M -43.44M -50.13M -73.64M -52.79M
-66K -256K -89K -304K -62K -168K -216.39K -44K – -331K -30K -25K -58.82K -933K -1.53M – -2.79M – -9.73M -1.32M – -24.45M –
– – – – – – -29.61K – -59K – – – -136.18K – – -4.58M – -7.17M – -8.95M -11.6M – -19.19M
-34.63M -34.18M -38.6M -32.56M -28.64M -34.63M -54.95M -47.29M -35.04M -38.43M -42.05M -40.66M -37.74M -40.09M -47.75M -40.27M -39.89M -44.33M -57.59M -34.49M -25.49M -58.39M -33.6M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.